Skip to content

Oral Probiotics on the Shift in Gut Microbiome and Skin Carotenoid Levels

Prospective Randomized Double-Blind Placebo Controlled Study of Oral Probiotics on the Shift of Gut Microbiome and Skin Carotenoid Levels

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04841694
Enrollment
25
Registered
2021-04-12
Start date
2021-06-01
Completion date
2022-03-31
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Microbiome

Keywords

gut microbiome, dermatology, skin, carotenoids, probiotics

Brief summary

The purpose of this study is to determine how probiotics affects circulating carotenoid levels.

Detailed description

Certain probiotic strains are rich in the production of carotenoids. This study will evaluate if probiotic supplementation with a carotenoid rich strain will augment circulating carotenoids.

Interventions

DIETARY_SUPPLEMENTProbiotic

Bacillus indicus

Sponsors

Microbiome labs
CollaboratorUNKNOWN
Integrative Skin Science and Research
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects aged 40+ * Must be willing to comply with all protocol requirements * Must be willing to have flash photo facial images taken with the imaging systems * Fitzpatrick skin type II, III, or IV

Exclusion criteria

* Any systemic or antibiotics (injected or oral) within 6 months of starting study * Any topical antibiotic or Vitamin A within 1 month of starting study or any subject unwilling to refrain from washout of topical antibacterial or vitamin A ingredient. * Any oral probiotic or prebiotic supplementation within past 1 month at the discretion of the investigator. * Limit total fruit and vegetable intake to 2.5 servings (1 serving=1 cup) per day of high carotenoid foods. High carotenoid foods include spinach, summer squash, carrots, citrus fruits, celery, kale, tomatoes, and cantaloupe * Subjects must have no history of malignancy or cancer (excluding skin cancer unless there is a history of metastasis) or diagnosis of gastrointestinal inflammatory diseases, no history or diagnosis of epilepsy, no history or diagnosis of immunologic or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS, lupus, rheumatoid arthritis) * Has a condition or is on medication the investigator and/or designee believe could jeopardize the safety of the subject, interfere with the evaluation, or confound the interpretation of the study results * Women who have been pregnant in the last three months, are pregnant, preparing to be pregnant or lactating. * Is participating in a concurrent intervention based clinical research study * Those with BMI higher than 35 kg/m² * Commencement of a new diet (such as the ketogenic diet) or supplements within the 1 month prior to initiating participation, at the discretion of the investigator. * Is participating in or has participated in a intervention based facial study at this or any other facility in the past 2 weeks. Participation in survey-based studies are approved at the discretion of the investigator. * Has a skin disease on face that will interfere with image collection and assessment in the opinion of the investigator * Refusal to shave or remove facial hair that may interfere with image collection and assessment. * Persons unwilling to avoid the following during the 4 weeks prior and during the duration of the study: self-tanning, spa tanning, sun tanning, or artificial tanning. * Known allergy or irritation to the supplement utilized in the study * Persons unwilling to avoid sun exposure to the inner forearm * Current tobacco smokers, OR those that have smoked tobacco over the past year, OR a 5 year-pack year history of smoking tobacco * Cutaneous photosensitivity at wavelengths of 400-450 nm * Porphyria or known allergies to porphyrins * Prisoners * Adults unable to consent

Design outcomes

Primary

MeasureTime frameDescription
Carotenoid Levels5 weeksChange in skin carotenoid level and blood carotenoid level with supplementation

Secondary

MeasureTime frameDescription
Assessment of GI related gas and constipationWeek 5self assessment using digestive health questionnaire
Shift in facial redness- image basedWeek 5BTBP Clarity Mini 3D camera
Gut Microbiome ChangesWeek 5Shift in gut microbiome diversity
Protection against blue light exposure induced change in skin colorWeeks 5Change in skin color measured by a skin colorimeter
Carotenoid Levels5 weeksChange in skin carotenoid level and blood carotenoid level with supplementation
Shift in facial pigmentation - image basedWeek 5BTBP Clarity Mini 3D camera

Countries

United States

Contacts

Primary ContactRaja K Sivamani, MD
raja.sivamani@integrativeskinresearch.com916-524-1216

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026